Atopic keratoconjunctivitis and atopic dermatitis

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 5, 2010, Pages 478-485

  Guglielmetti, Stefano ^a   Dart, John Kg ^a,b   Calder, Virginia ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atopic dermatitis; atopic keratoconjunctivitis; ciclosporin A; IL 33; tacrolimus; thymic stromal lymphopoetin

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CHROMONE DERIVATIVE; CYCLOSPORIN A; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 33; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OPTIMMUNE; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; ATOPIC KERATOCONJUNCTIVITIS; BASOPHIL; CONJUNCTIVA EPITHELIUM; EFFECTOR CELL; EOSINOPHIL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REVIEW;

BASOPHILS; CONJUNCTIVITIS, ALLERGIC; CYCLOSPORINE; CYTOKINES; DERMATITIS, ATOPIC; DRUG RESISTANCE; EOSINOPHILS; EPITHELIAL CELLS; HUMANS; INTERLEUKINS; KERATOCONJUNCTIVITIS; TACROLIMUS;

EID: 77956238029     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833e16e4     Document Type: Review

References (40)

1. Leonardi A, De Dominicis C, Motterle L Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 2007; 7:429-435.
2. Hogan MJ. Atopic keratoconjunctivitis. Trans Am Ophthalmol Soc 1952; 50:265-281.
3. Calonge M, Herreras JM. Clinical grading of atopic keratoconjunctivitis. Curr Opin Allergy Clin Immunol 2007; 7:442-445.
4. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ. Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991; 98:150-158.
5. Leonard JN, Dart JK. The skin and the eyes. In: Burns T, Breathnach S, Cox N, Griffiths, editors. Rook's textbook of dermatology. Oxford: Wiley-Blackwell; 2010. Chapter 67.
6. Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000; 106:1019-1032.
7. Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006; 144:1-9.
8. Tuft SJ, Ramakrishnan M, Seal DV, et al. Role of Staphylococcus aureus in chronic allergic conjunctivitis. Ophthalmology 1992; 99:180-184.
9. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-1160.
10. Imayama S, Shimozono Y, Hoashi M, et al. Reduced secretion of IgA to skin surface of patients with atopic dermatitis. J Allergy Clin Immunol 1994; 94:195-200.
11. Toshitani A, Imayama S, Shimozono Y, et al. Reduced amount of secretory component of IgA secretion in tears of patients with atopic dermatitis. J Dermatol Sci 1999; 19:134-138.
12. Pelikan Z. The possible involvement of nasal allergy in allergic keratoconjunctivitis. Eye (Lond) 2009; 23:1653-1660.
13. Friedlaender MH. Conjunctivitis of allergic origin: clinical presentation and differential diagnosis. Surv Ophthalmol 1993; 38 (Suppl):105-114.
14. Bacon AS, Tuft SJ, Metz DM, et al. The origin of keratopathy in chronic allergic eye disease: a histopathological study. Eye (Lond) 1993; 7 (Pt 3 Suppl):21-25.
15. Matsuda A, Ebihara N, Yokoi N, et al. Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci 2010; 51:151-155.
16. Enriquez-de-Salamanca A, Calder V, Gao J, et al. Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine 2008; 44:160-167.
17. Metz DP, Hingorani M, Calder VL, et al. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997; 100:817-824.
18. Matsuda A, Okayama Y, Terai N, et al. The role of interleukin-33 in chronic allergic conjunctivitis. Invest Ophthalmol Vis Sci 2009; 50:4646-4652.
19. Hingorani M, Calder V, Jolly G, et al. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 1998; 102:821-830.
20. Montan PG, Van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 1996; 80:556-560.
21. Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology 2003; 110:487-492.
22. Ueta M, Uematsu S, Akira S, Kinoshita S. Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol 2009; 123:1187-1189.
23. Matsuda A, Ebihara N, Yokoi N, et al. Basophils in the giant papillae of chronic allergic keratoconjunctivitis. Br J Ophthalmol 2009; 106:1516-1523.
24. Ying S, O'Connor B, Ratoff J, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174:8183-8190.
25. Wakamatsu TH, Okada N, Kojima T, et al. Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC). Mol Vis 2009; 15:1611-1619.
26. Nivenius E, Van Der Ploeg I, Jung K, et al. Tacrolimus ointment vs. steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Eye (Lond) 2007; 21:968-975.
27. Remitz A, Reitamo S. Long-term safety of tacrolimus ointment in atopic dermatitis. Expert Opin Drug Saf 2009; 8:501-506.
28. Remitz A, Virtanen HM, Reitamo S, Kari O. Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure. Acta Ophthalmol 2010. [Epub ahead of print]
29. Zribi H, Descamps V, Hoang-Xuan T, et al. Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol 2009; 23:489-490.
30. Tesse R, Spadavecchia L, Fanelli P, et al. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children. Pediatr Allergy Immunol 2010; 21 (2 Pt 1):330-335.
31. Kilic A, Gurler B. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Can J Ophthalmol 2006; 41:693-698.
32. Akpek EK, Dart JK, Watson S, et al. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 2004; 111:476-482.
33. Daniell M, Constantinou M, Vu HT, Taylor HR. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol 2006; 90:461-464.
34. Ebihara N, Ohashi Y, Uchio E, et al. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther 2009; 25:365-372.
35. Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, et al. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology 2008; 115:988-992; e985.
36. Hoang-Xuan T, Prisant O, Hannouche D, Robin H. Systemic cyclosporine A in severe atopic keratoconjunctivitis. Ophthalmology 1997; 104:1300-1305.
37. Nochez Y, Denoyer A, Pisella PJ. 0.05% cyclosporine a for treatment of chronic severe ocular surface disease. Can J Ophthalmol 2009; 44:406-411.
38. Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24:317-328.
39. Buckley RJ. Vernal keratopathy and its management. Trans Ophthalmol Soc U K 1981; 101:234-238.
40. Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology 1995; 102:985-993.